Citigroup Lowers Xenon Pharmaceuticals (NASDAQ:XENE) Price Target to $60.00 dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.
Xenon Pharmaceuticals (NASDAQ:XENE – Get Free Report)‘s stock had its “overweight” rating reaffirmed by Cantor Fitzgerald in a research report issued to clients and investors on Wednesday, Benzinga reports. They presently have a $65.00 price objective on the biopharmaceutical company’s stock. Cantor Fitzgerald’s price target indicates a potential upside of 52.19% from the company’s current […]
Xenon Pharmaceuticals (NASDAQ:XENE – Free Report) had its price target hoisted by JPMorgan Chase & Co. from $54.00 to $59.00 in a report published on Tuesday morning, BayStreet.CA reports. The firm currently has an outperform rating on the biopharmaceutical company’s stock. A number of other research firms also recently weighed in on XENE. Stifel Nicolaus […]
Stock Traders Purchase Large Volume of Put Options on Xenon Pharmaceuticals (NASDAQ:XENE) themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Xenon Pharmaceuticals Inc. (NASDAQ:XENE – Get Free Report) was the recipient of some unusual options trading activity on Wednesday. Investors acquired 4,063 put options on the company. This is an increase of 2,362% compared to the typical daily volume of 165 put options. Analyst Upgrades and Downgrades A number of analysts have recently issued reports […]